Product Compliance And Certification For Wearable Medical Device In India

Scope and evidence must be confirmed before any paid tests or filings.

A wearable sold in India may be a lifestyle tracker, a regulated medical device, or a connected system whose watch, sensor, app and cloud service require separate analysis. The first decision is the intended medical purpose communicated on the label, in instructions, in the app and in advertising—not whether the hardware resembles a smartwatch. Complete the product map below before choosing a test house, licence application or import route.

Start with the claim, not the wristband

CDSCO describes a medical device by its intended medical purpose, including diagnosis or monitoring of disease; its July 2026 software guidance expressly distinguishes fitness-only tracking with no medical purpose. An ECG trace, SpO₂ number or AI score does not automatically establish a risk class. Document what clinical decision the output supports, who receives it, and what happens if it is wrong. India uses Classes A–D; the class follows the MDR rules and current CDSCO device/software classification, not a marketing category. The Class A non-sterile/non-measuring exemption is conditional on CDSCO registration and cannot be applied to a measuring medical wearable just because its risk appears low.

The licensing exemption comes from G.S.R. 777(E) of 14 October 2022 and is conditional on Chapter IIIB registration. The 2025 CDSCO Class A list helps identify products but is not the legal instrument creating the exemption. The July 2026 CDSCO software document is guidance explaining the existing MDR, not a separate statute.

Five wearable configurations that change the route

Example configuration	Classification trigger	Question to resolve
Step-counting band with sleep and exercise trends	Only general lifestyle or fitness purposes are claimed	Do any app screens, ads or clinical partnerships imply diagnosis, disease alerts or therapy?
Wrist ECG with atrial-fibrillation warning	Detection/monitoring of a disorder can bring hardware and algorithm within MDR	Is it a diagnostic claim, screening aid or raw trace; what decisions follow an alert?
Pulse-oximeter ring for home monitoring	Medical SpO₂ monitoring is unlike an unclaimed wellness estimate	Which population, alarm thresholds, accuracy and use environment are specified?
Skin patch or continuous glucose sensor with phone app	Sensor, adhesive, transmitted measurements and software form a medical-use system	Which component is marketed separately, and is a predicate device available?
Cloud/AI dashboard that triages clinician alerts	Medical-purpose standalone software may require its own regulatory route	Is it a separate product, or embedded/controlled software assessed with the parent device?

India’s overlapping approval map

Regulatory layer	When to investigate	Launch evidence / owner
CDSCO / state licensing	Medical intended use of the wearable, sensor and/or software	Classify under MDR; import ordinarily MD-14 → MD-15 through the Indian authorised agent; Indian manufacturing route depends on class (A/B state, C/D centre). Check registration exception only where actually eligible.
BIS compulsory registration	A finished smartwatch, notified portable cell/battery or bundled notified power adapter	Match exact product category and current BIS standard/transition; the official CRS list expressly includes “Smart watches”, portable secondary cells/batteries and certain adapters. Do not assume all rings or patches are smart watches.
DoT / WPC radio ETA	Bluetooth, Wi-Fi or another transmitter using Indian licence-exempt bands	Verify band, power and RF report; WPC lists smart watches among self-declaration ETA products. Cellular/satellite variants must be assessed separately, not assumed eligible for that route.
Battery waste EPR	A producer/importer places batteries in India	Identify Indian producer and CPCB battery EPR registration/obligations under the Battery Waste Management Rules; the battery being built-in is not a blanket exemption.
Electronic-waste EPR	Electrical/electronic product falls into the notified e-waste schedule	Check equipment code/category and producer status separately; medical functions do not automatically remove scheduled electronics from the analysis. In Schedule I of the 2022 rules, cardiology equipment/accessories (MDW2) and other electronic disease-monitoring equipment (MDW10) are possible checks; implanted and infected products are expressly excepted. Classification by actual SKU is necessary.
Retail package / other trade rules	Pre-packaged product offered for retail sale	Check applicable Legal Metrology declarations and importer particulars separately from MDR device labelling; exemptions depend on packaging and sale channel.
Digital personal data	App/cloud processes identifiable patient or consumer data	For identifiable health data, identify the body corporate handling the information and assess currently applicable IT Act 2000 section 43A and the 2011 SPDI Rules (health records, privacy notices, consent and reasonable security, as applicable). Map future DPDP data-fiduciary/processor roles separately: the DPDP Act 2023 and Rules 2025 commence in stages, so do not treat their future duties as already operative in October 2026.

This is an applicability matrix, not seven automatic certificates. Requirements can run in parallel and attach to different legal entities or parts of the same SKU. A CDSCO permission does not itself establish BIS, radio, EPR or privacy compliance.

Wearable-specific evidence pack before filing

Build one SKU-and-claim register that links each claimed function to its responsible product element. For each India variant collect:

Exact intended-use and indications text across carton, instructions, website, app-store listing and clinician dashboard; identify the target patient and user.
Bill of materials and system diagram showing sensors, adhesives, firmware, app, cloud, radio modules, battery and supplied charger, with model/variant mapping.
Risk classification rationale with applicable CDSCO list or First Schedule rule, predicate comparison where relevant and unresolved classification questions.
Clinical/performance substantiation for the advertised output: comparator, accuracy limits, false alerts/misses, motion and skin-tone or population effects where relevant.
Bench, electrical/battery, electromagnetic, skin-contact/biocompatibility, usability and radio evidence as applicable; tests and standards are selected by risk, not assumed universal certificates.
QMS/manufacturing-site evidence, Indian importer/authorised-agent details and actual licensing or registration holder for each applicable route.
Software version, cybersecurity/risk file, update and rollback plan, data-flow map, adverse-event reporting and field-correction responsibilities.

Claims, packaging and patient-facing instructions

Before artwork freeze, reconcile the exact approved medical intended use with the label, instructions and promotional claims. For applicable medical devices verify MDR labelling requirements including product identification, manufacturer/importer particulars, lot/serial traceability, warnings and directions, and any relevant registration/licence information. A watch-like form factor can additionally trigger BIS markings; retail packs can require their own declarations. Never print a BIS number, CDSCO licence claim or approval logo merely because an application was filed. Translate or adapt patient-facing instructions to the intended Indian users and assess readability; do not invent an across-the-board Hindi-only labelling rule.

Release gates for an India launch

Gate	Release decision
1 — Lock the claim	Freeze clinical indications and screenshots, and separate fitness features from medical alerts.
2 — Resolve product boundaries	Decide which device/software elements and variants are covered by each classification/registration. Where uncertain, use CDSCO’s classification/clarification channel.
3 — Verify the entity and approvals	Confirm Indian authorised agent/importer, CDSCO route, BIS product matching, WPC band/ETA, EPR and package responsibilities.
4 — Match released evidence	Make test reports, clinical data, software build, radio configuration and final carton match the actual import SKU.
5 — Authorise distribution and monitoring	Release only after all applicable permissions/registrations are effective; establish complaints, safety reporting, recalls and software rollback.

Changes that reopen the compliance assessment

Treat new marketing claims and engineering changes as regulatory triggers, not only product-management releases: (a) a wellness ring adds arrhythmia detection—repeat the medical-device qualification and evidence analysis; (b) a licensed ECG patch changes its algorithm or alert threshold—assess clinical risk, software validation and CDSCO post-approval-change obligations; (c) a smartwatch switches cell supplier or enables a new Wi-Fi band—recheck BIS scope, battery evidence and radio ETA. A consumer-app feature flag can change the regulated intended use without changing physical hardware.

For the general Indian medical-device licensing framework rather than this wearables-specific cross-regime map, see medical-device compliance in India.

Wearable medical-device questions

Does every Indian fitness band need a CDSCO licence?: No blanket conclusion follows from wearing it on the body. Check actual intended use and every medical claim. Pure fitness-only software may fall outside the medical-device definition, while ECG, disease monitoring or therapeutic decisions can change the result; separate electronics/radio checks still apply.
Is an ECG smartwatch always Class B?: No. Neither the sensor name nor a foreign approval fixes the Indian class. Use the clinical intended use, consequence of an incorrect output, applicable CDSCO classification lists/First Schedule and the software role; seek classification clarification where unresolved.
Can an imported watch be launched with CE marking or US FDA clearance alone?: No. Foreign evidence may support the dossier but does not replace Indian medical-device requirements or any applicable BIS, WPC, packaging and producer obligations. For licensed imports, identify the Indian authorised agent and exact permitted models.
Does the accompanying mobile app need a separate licence?: It depends on its function and how it is supplied. CDSCO’s July 2026 guidance says embedded/control software may be licensed with parent hardware, while software supplied separately for a medical purpose can require separate licensing. Keep the app/cloud boundaries explicit.
Can a Class A non-sterile/non-measuring exception cover a pulse-measuring watch?: Do not assume so. The 2022 exception addresses eligible Class A non-sterile/non-measuring devices subject to registration; measuring medical wearables cannot claim it solely from a “low-risk” marketing description; being powered alone is not the legal exemption test. Verify the exact classification and exception conditions.